FFCP PHASE1:Hg19::chr21:26796921..26796933,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene= | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_ncRNA | |||
|HGNC=1283 | |||
|TSSclassifier=strong | |||
|UniProt= | |||
|association_with_transcript=87bp_to_ENST00000440205_5end | |||
|cluster_id=chr21:26796921..26796933,- | |||
|coexpression_cluster_id=C38 | |||
|description=CAGE_peak_8_at_LINC00158_5end | |||
|id=chr21:26796921..26796933,- | |||
|ontology_enrichment_celltype=CL:0000945!6.64e-40!24;CL:0000826!6.64e-40!24;CL:0000542!8.03e-28!53;CL:0000051!8.03e-28!53;CL:0000838!5.77e-23!52;CL:0000946!2.25e-16!1;CL:0000786!2.25e-16!1;CL:0000980!2.25e-16!1;CL:0002087!8.40e-12!119;CL:0000738!6.73e-10!140;CL:0002031!4.29e-09!124;CL:0000785!7.49e-09!2;CL:0000955!7.49e-09!2;CL:0000818!7.49e-09!2;CL:0000954!7.49e-09!2;CL:0000816!7.49e-09!2;CL:0002032!2.97e-08!165;CL:0000837!2.97e-08!165;CL:0000037!7.07e-08!172;CL:0000566!7.07e-08!172;CL:0000988!2.18e-07!182 | |||
|ontology_enrichment_celltype_v019=CL:0000138;7.67e-18;6!CL:0000153;2.19e-12;9!CL:0000447;2.19e-12;9!CL:0000327;5.55e-08;15 | |||
|ontology_enrichment_celltype_v019_2=CL:0000058,7.67e-18,6;CL:0000138,7.67e-18,6;CL:0000153,2.19e-12,9;CL:0000447,2.19e-12,9;CL:0000327,5.55e-08,15 | |||
|ontology_enrichment_development_v019= | |||
|ontology_enrichment_disease=DOID:0060058!1.18e-24!10;DOID:3371!4.72e-17!1;DOID:4549!4.72e-17!1;DOID:5861!4.72e-17!1;DOID:6496!4.72e-17!1;DOID:630!6.47e-17!1;DOID:0050177!6.47e-17!1;DOID:0050427!6.47e-17!1;DOID:0060060!1.21e-16!1;DOID:0060061!1.21e-16!1;DOID:8691!1.21e-16!1;DOID:12603!1.41e-16!1;DOID:2531!1.73e-07!51;DOID:0060083!1.73e-07!51 | |||
|ontology_enrichment_disease_v019=DOID:3371;9.37e-99;1!DOID:4549;9.37e-99;1!DOID:5861;9.37e-99;1!DOID:6496;9.37e-99;1!DOID:201;7.67e-18;6!DOID:0060100;7.67e-18;6!DOID:0060058;3.02e-11;10 | |||
|ontology_enrichment_disease_v019_2=DOID:3371,9.37e-99,1;DOID:4549,9.37e-99,1;DOID:5861,9.37e-99,1;DOID:6496,9.37e-99,1;DOID:201,7.67e-18,6;DOID:0060100,7.67e-18,6;DOID:0060058,3.02e-11,10 | |||
|ontology_enrichment_uberon= | |||
|ontology_enrichment_uberon_v019=UBERON:0002418;4.27e-34;3!UBERON:0004755;4.27e-34;3!UBERON:0001474;7.18e-07;18 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002418,4.27e-34,3;UBERON:0004755,4.27e-34,3 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.229240217243854,0.0821005894499457,0.550975469195755,0,0,0,0,0,0,0,1.27952309238679,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.185803175125719,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.123084805461069,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.23629408119201,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.121792598380896,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.19998739585493,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.115233987555779,0,0,0,0,0,0,0,0,0,0,0,0,0,0.348724276104376,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0999411559249289,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.641136984606466 | |||
|short_description=p8@LINC00158 | |||
}} |
Latest revision as of 21:47, 17 September 2015
Short description: | p8@LINC00158 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_8_at_LINC00158_5end |
Coexpression cluster: | C38_extraskeletal_rhabdomyosarcoma_adrenal_rectal_mesothelioma_lung_Wilms |
Association with transcript: | 87bp_to_ENST00000440205_5end |
EntrezGene: | NA |
HGNC: | 1283 |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
chondroblast | 7.67e-18 | 6 |
chondrocyte | 7.67e-18 | 6 |
GAG secreting cell | 2.19e-12 | 9 |
carbohydrate secreting cell | 2.19e-12 | 9 |
extracellular matrix secreting cell | 5.55e-08 | 15 |
Ontology term | p-value | n |
---|---|---|
cartilage tissue | 4.27e-34 | 3 |
skeletal tissue | 4.27e-34 | 3 |
Ontology term | p-value | n |
---|---|---|
chondrosarcoma | 9.37e-99 | 1 |
extraosseous chondrosarcoma | 9.37e-99 | 1 |
myxoid chondrosarcoma | 9.37e-99 | 1 |
extraskeletal myxoid chondrosarcoma | 9.37e-99 | 1 |
connective tissue cancer | 7.67e-18 | 6 |
musculoskeletal system cancer | 7.67e-18 | 6 |
lymphoma | 3.02e-11 | 10 |